(Q37846531)

24 August 2017

title

Challenges in obtaining adequate genetic sample sets in clinical trials: the perspective of the industry pharmacogenomics working group (English)

1 reference

24 August 2017

1 reference

A W Warner

1

1 reference

24 August 2017

A Bhathena

2

1 reference

24 August 2017

S Gilardi

3

1 reference

24 August 2017

D Mohr

4

1 reference

24 August 2017

D Leong

5

1 reference

24 August 2017

K L Bienfait

6

1 reference

24 August 2017

J Sarang

7

1 reference

24 August 2017

S Duprey

8

1 reference

24 August 2017

M A Franc

9

1 reference

24 August 2017

A Nelsen

10

1 reference

24 August 2017

A Snapir

11

1 reference

24 August 2017

language of work or name

English

0 references

publication date

23 February 2011

1 reference

Clinical Pharmacology & Therapeutics

24 August 2017

published in

1 reference

24 August 2017

volume

89

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

529-536

1 reference

Returning genetic research results to individuals: points-to-consider

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Reporting genetic results in research studies: summary and recommendations of an NHLBI working group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Drug development: assessment of pharmacogenetic studies by Spanish research ethics committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Problematic variation in local institutional review of a multicenter genetic epidemiology study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Interventions to improve research participants' understanding in informed consent for research: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Patients' and physicians' perspectives on pharmacogenetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Participant characteristics that influence consent for genetic research in a population-based survey: the Baltimore epidemiologic catchment area follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Obtaining informed consent for genetic studies: The multiethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Willingness to donate blood samples for genetic research: a survey from a community in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Warranted concerns, warranted outlooks: a focus group study of public understandings of genetic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Genetic information and testing in insurance and employment: technical, social and ethical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

Public willingness to participate in and public opinions about genetic variation research: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.305

21 January 2018

Identifiers

DOI

10.1038/CLPT.2010.305

1 reference

24 August 2017

1 reference